Tribunal decision: R&D deduction disallowed, 14A expenses remanded, net profit addition deleted

The Tribunal upheld the disallowance of weighted deduction claimed by the assessee on scientific research under section 35(2AB), stating that only expenditures on in-house R&D facilities are eligible. Regarding the disallowance of expenses related to exempt income under section 14A, the Tribunal set aside the CIT(A)'s decision and remanded the matter for re-examination in light of the Mumbai High Court's ruling that Rule 8D is not retrospective. The Tribunal also upheld the deletion of the estimated net profit addition, finding no justification for the Assessing Officer's approach. The final result was that the assessee's appeal was partly allowed, while the revenue's appeal was dismissed.

---

---

Issues Involved:
1. Disallowance of weighted deduction claimed by the assessee on scientific research under section 35(2AB) of the Income-tax Act.
2. Disallowance of expenses in relation to the exempt income under section 14A of the Income-tax Act.
3. Addition of estimated net profit by the Assessing Officer.

Detailed Analysis:

1. Disallowance of Weighted Deduction on Scientific Research (Section 35(2AB)):
Background:
The assessee claimed a weighted deduction of Rs. 359.87 lakhs under section 35(2AB), which included Rs. 14.89 lakhs incurred outside the in-house R&D facility. The Assessing Officer disallowed this amount, stating that section 35(2AB) pertains only to in-house R&D.

Arguments:
- Assessee's Argument: Clinical trials are integral to scientific research in pharmaceuticals, and the Explanation to section 35(2AB) includes such trials. They cited CBDT Circulars and the Gujarat High Court's judgment in CIT v. Claris Lifesciences Ltd.
- Revenue's Argument: Only expenditures incurred on in-house R&D facilities are eligible for weighted deduction.

Tribunal's Decision:
The Tribunal upheld the disallowance, stating:
- Section 35(2AB) explicitly requires expenditures to be on in-house R&D facilities.
- The Explanation clarifies that clinical trials are part of scientific research but does not extend to expenditures outside in-house facilities.
- The cited circulars and case laws do not support the claim for expenditures outside in-house R&D.

Conclusion:
The Tribunal confirmed that only expenditures incurred on in-house R&D facilities are eligible for weighted deduction under section 35(2AB).

2. Disallowance of Expenses Related to Exempt Income (Section 14A):
Background:
The assessee made investments generating exempt income but did not allocate any interest expenditure towards these investments. The Assessing Officer disallowed Rs. 4.80 lakhs on a proportionate basis, which CIT(A) upheld under Rule 8D.

Arguments:
- Assessee's Argument: Rule 8D should not be applied retrospectively.
- Revenue's Argument: Supported the application of Rule 8D.

Tribunal's Decision:
The Tribunal noted that:
- The Mumbai High Court in Godrej & Boyce Mfg. Co. Ltd. v. Dy. CIT ruled that Rule 8D is not retrospective and applies only from the assessment year 2008-09.
- For prior periods, the AO must determine the expenditure on a reasonable basis after considering relevant facts and circumstances.

Conclusion:
The Tribunal set aside the CIT(A)'s order and remanded the matter back for re-examination in light of the Mumbai High Court's judgment, allowing the assessee a hearing opportunity.

3. Addition of Estimated Net Profit:
Background:
The Assessing Officer noted discrepancies in the net profit declared in the revised return and estimated a net profit addition of Rs. 55.36 lakhs. CIT(A) deleted this addition, noting that the revised return was supported by the correct audit report, and the profit margins were better than the previous year.

Arguments:
- Assessee's Argument: No defects were found in the books, and the revised return matched the audit report for the correct assessment year.
- Revenue's Argument: Supported the estimated addition based on discrepancies in the original return.

Tribunal's Decision:
The Tribunal found:
- The revised return should be considered as it matched the correct audit report.
- The net profit and operating margin were better than the previous year, justifying no need for estimated addition.

Conclusion:
The Tribunal upheld CIT(A)'s decision to delete the estimated addition, finding no justification for the Assessing Officer's approach.

Final Result:
- The assessee's appeal is partly allowed.
- The revenue's appeal is dismissed.

---